• Cellumed will hold an extraordinary shareholders meeting on November 27, 2026, at KSA Gasan Center in Seoul.
• Shareholders will vote on canceling 18,761,339 shares held by the largest shareholder without compensation, reducing outstanding shares by 22.54% to cover losses.
• The proposed capital reduction would leave 64,464,853 shares outstanding, with December 15, 2026, as the reference date.
• Other proposals cover fiscal 2025 standalone and consolidated financial statements, amendments to the articles of incorporation, and two director appointments.
• Proposed compensation ceilings remain unchanged at KRW 1.5 billion for directors and KRW 100 million for the auditor.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellumed Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261113000002), on November 13, 2026, and is solely responsible for the information contained therein.